Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  IDH2 inhibitor AG-221
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Phase 1 Study of AG-221 in Subjects With Advanced Hematologic Malignancies With an IDH2 Mutation
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: AG221-C-001, NCI-2013-01928, NCT01915498
Start Over